StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 2 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Results 1 - 20 of 87 : 1 2 3 4 5 Next »

Recs

0
Member Avatar Tophinater (37.86) Submitted: 10/23/2014 2:33:59 PM : Underperform Start Price: $1.17 STEM Score: +23.23

Nope!

Recs

3
Member Avatar zzlangerhans (99.85) Submitted: 4/30/2014 9:19:01 AM : Outperform Start Price: $1.25 STEM Score: -33.32

Wow, two hold-my-nose green thumbs on stem cell stocks in one day. Looks like the tide has been running out on this malodorous little corner of the biopharma sector since Athersys became the latest of the coterie to faceplant. Nevertheless, in bio all is soon forgiven and I think Stemcells will be headed back upward once enrollment is completed in the thoracic spinal cord injury trial and the AMD trial. Of course, with a stock like Stemcells it can be hard to tell when you'll get caught up in a harsh below market dilutive financing so this stock will never have sufficient texture for a zzporte trade.

Recs

0
Member Avatar ferrariedgardo (28.15) Submitted: 1/16/2014 6:56:27 PM : Outperform Start Price: $1.59 STEM Score: -51.72

Some potential here

Recs

0
Member Avatar paigecoverdale (< 20) Submitted: 1/13/2014 3:38:31 PM : Outperform Start Price: $1.52 STEM Score: -50.60

Doubler

Recs

0
Member Avatar mjbizdev (< 20) Submitted: 11/11/2012 7:40:16 AM : Underperform Start Price: $1.76 STEM Score: +94.40

This name repersents the amplification of near term collection of "false hopes" IMHO. I think investors will be dissapointed and dissillusioned in a significant way. I'd like to short this on weakness and buy after exhaustion selling over and over again. Just not in my focus to track.

Recs

1
Member Avatar STRIVE2BGR8 (< 20) Submitted: 5/3/2012 3:40:19 AM : Outperform Start Price: $0.93 STEM Score: -43.90

These are long haul companies. There's LOTS of break through movements in stem cell research and applications. Texas just made law to free up stem cell research, development and experimental treatments, that do not require FDA approval. (The governor just had stem cell therapy on his back, and is a big advocate.) Though not all the companies may flourish, at penny stock rates, the loss possibility is marginal. The gain potential however, is phenomenal. I'm betting some of these companies will easily break $10/share in the next 3 years.. with potential into the mid $30's in 5 yrs.

Recs

0
Member Avatar Gerf1 (< 20) Submitted: 9/20/2011 10:07:57 AM : Outperform Start Price: $2.38 STEM Score: -131.00

this research will be very beneficial to help humans in so many ways, should also make $$$ if succesufull and managed correctly, and used for good not bad.

Recs

1
Member Avatar Euro247 (35.38) Submitted: 7/19/2011 2:14:45 PM : Outperform Start Price: $3.83 STEM Score: -131.00

TSIF

Recs

0
Member Avatar KimLanners (< 20) Submitted: 7/7/2011 10:42:06 AM : Outperform Start Price: $4.87 STEM Score: -133.08

stemcells

Recs

1
Member Avatar stemcells2011 (88.39) Submitted: 4/13/2011 11:52:09 AM : Outperform Start Price: $7.85 STEM Score: -145.09

Stem cells

Recs

0
Member Avatar Covestor (59.80) Submitted: 3/14/2011 3:06:38 PM : Outperform Start Price: $8.44 STEM Score: -147.66

Covestor Model Manager Joe Agresti bought STEM in his China & India Covestor Model ( http://covestor.com/Joe-Agresti )

Recs

0
Member Avatar HollowMountain (< 20) Submitted: 2/18/2011 4:33:19 AM : Outperform Start Price: $9.65 STEM Score: -143.73

I keep doing screens to find new ideas, and I always run into this one, I like the sector and the fundamentals aren't TOO bad. Plus with a possible first mover in a hyped sector, this could pop on speculation alone.

Recs

0
Member Avatar samdeva (46.68) Submitted: 1/21/2011 3:18:41 PM : Outperform Start Price: $9.80 STEM Score: -150.83

Mostly intuition (sorry, could have better explanation). I picked AMRN in 2008 from my intuition, which gave me 300% return in 2 years. So, trusting my intuition again.

Recs

0
Member Avatar FRESHTASTIC (52.46) Submitted: 11/22/2010 2:39:12 AM : Outperform Start Price: $11.50 STEM Score: -164.19

nice

Recs

0
Member Avatar whomonkyoulus (28.55) Submitted: 8/19/2010 4:35:32 AM : Outperform Start Price: $11.40 STEM Score: -180.65

I am not going to try to time this one. I think that this will be worth a billion USD in 5 more years.

Recs

3
Member Avatar jkleiman (47.57) Submitted: 10/5/2009 3:36:52 PM : Outperform Start Price: $15.30 STEM Score: -192.43

Hard to value a stock like this. It's a long-term buy. Eventually stem cells will play a huge rule in modern medicine. When is only a matter of time, and Bush or Jesus or any of their pals can always set science back

Recs

0
Member Avatar englandstumpy (20.34) Submitted: 8/5/2009 1:54:11 PM : Outperform Start Price: $16.90 STEM Score: -200.50

Obama is infavor of this research and will remove restrictions and possibly add funding.

Recs

0
Member Avatar Wiseinvest70 (42.80) Submitted: 7/27/2009 2:46:29 PM : Outperform Start Price: $18.00 STEM Score: -206.13

Stem cell research will be one of the major technologies in the years to come, at this moment is like buying the coke recipe for a peanuts, in my time frame I'm suggesting a 2 to 4 year period, but this baby is a one to keep for at least 10 years where we will see a major change in the way we know health industry.

Recs

0
Member Avatar matgol (32.53) Submitted: 5/7/2009 12:21:34 PM : Outperform Start Price: $17.00 STEM Score: -222.66

Waiting for more legislation on this, but will pop in the next few years.

Recs

0
Member Avatar bigbonesmagoo (28.22) Submitted: 5/1/2009 9:14:22 AM : Outperform Start Price: $16.80 STEM Score: -232.93

I like ASTM better but I think the whole stem cell sector will move on some upcoming good news...

Results 1 - 20 of 87 : 1 2 3 4 5 Next »

Featured Broker Partners


Advertisement